Cardinal Health Inc
Wholesale drugs, proprietaries & druggists’ sundries10 peers
- Last sale
- Nov 12, 2026 · +0.27%
- Market cap
- $64.30B
- 231.14M shares
- Filings
- 1,072
Q1 2027+14.2% FY26 yoy
Q1 2027+9.8% FY26 yoy
Q1 2027+14.9% FY26 yoy
Q1 2027derived+144.6% FY26 yoy
Q1 2027+12.1% FY26 yoy
Q1 2027+25.3% FY26 yoy
- $64.30B
- 37.5×
- 0.3×
- —
- 7.04%
- 0.76%
FY2026 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-06-30 | $254,248,000,000 | reported | |
| FY 2025 | 2025-06-30 | $222,578,000,000 | reported | |
| FY 2024 | 2024-06-30 | $226,827,000,000 | reported | |
| FY 2023 | 2023-06-30 | $204,979,000,000 revised | reported | |
| FY 2022 | 2022-06-30 | $181,326,000,000 revised | reported | |
| FY 2021 | 2021-06-30 | $162,467,000,000 | reported | |
| FY 2020 | 2020-06-30 | $152,922,000,000 | reported | |
| FY 2019 | 2019-06-30 | $145,534,000,000 | reported | |
| FY 2018 | 2018-06-30 | $136,809,000,000 | reported | |
| FY 2017 | 2017-06-30 | $129,976,000,000 | reported | |
| FY 2016 | 2016-06-30 | $121,546,000,000 | reported | |
| FY 2015 | 2015-06-30 | $102,531,000,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2026 | $491.00M | $1.36B | $1.85B | $2.04 | 232.58M sh | −2.6% | 40.9% |
| FY2025 | $494.00M | $765.00M | $1.26B | $2.02 | 238.79M sh | −2.1% | 68.1% |
| FY2024 | $499.00M | $750.00M | $1.25B | $2.00 | 243.85M sh | −2.7% | 38.4% |
| FY2023 | $525.00M | $2.00B | $2.53B | $1.98 | 250.68M sh | −8.0% | 106.9% |
| FY2022 | $559.00M | $1.00B | $1.56B | $1.96 | 272.51M sh | −6.2% | 55.9% |
Segments
LineFY2026ShareChange
Pharmaceutical and Specialty Solutions$234.83B92%+14.8%
GMPD$12.72B5.0%+0.7%
Other Operating Segment$6.79B2.7%+26.2%
Medical———
Pharmaceutical———
Total$254.25B
Wholesale drugs, proprietaries & druggists’ sundries
Cardinal Health Inc is the 3rd largest of the 11 covered companies the SEC files under this code, by revenue. SIC 5122
CompanyRevenueGrowthNet marginMarket cap
MCKMcKesson Corp$403.4B12.4%1.2%$124.3BCORCencora, Inc.Fiscal 2025 figures$321.3B9.3%0.5%$66.7B
CAHCardinal Health Inc (this company)$254.2B14.2%0.7%$64.3B
HLFHerbalife Ltd.$5.0B0.9%4.5%$1.6BNUSNU Skin Enterprises, Inc.$1.5B14.3%10.8%$195.7MCOSMCosmos Health Inc.$65.3M19.9%29.3%$20.8MMEDSDataMeds AI, Inc.$23.3M28.7%433.9%$4.1MSTEKStemtech Corp$2.9M43.1%140.7%$1.6MESYNEnerSyn Global Inc.$866.9K30.8%303.4%$46.4MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Cardinal Health Inc · CIK 721371 · Engraved from SEC EDGAR